ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

White Biotechnology Market Analysis and Forecast Report 2025-2034: Strategic Alliances and M&As Set to Shape White Biotechnology Landscape - ResearchAndMarkets.com

The "White Biotechnology Market - A Global and Regional Analysis: Focus on Application, Product, and Country Analysis - Analysis and Forecast, 2025-2034" report has been added to ResearchAndMarkets.com's offering.

White biotechnology also known as industrial biotechnology leverages living cells, enzymes and fermentation processes to produce bio-based chemicals, materials and energy carriers. Core application areas include biofuels (e.g., advanced biodiesel and bioethanol), biochemicals (organic acids, solvents), industrial enzymes (for detergents, textiles, food processing), biomaterials (biopolymers, bioplastics) and emerging fields such as bioremediation and renewable feedstock valorization.

Technological advances in synthetic biology, metabolic engineering and protein engineering are enabling more efficient strain development, higher yields and reduced process costs. Concurrently, digital tools - machine learning for bioprocess optimization, high-throughput screening and scalable continuous-flow fermentation - are accelerating time-to-market for new bioproducts. This convergence of biology and digitalization is driving white biotechnology market's transformation from niche specialty applications toward large-scale industrial adoption.

The white biotechnology market is firmly in its growth phase, characterized by robust R&D investment, rapid technology commercialization and an expanding base of both established chemical-industry incumbents and agile biotech startups. Market concentration remains moderate, with innovation dispersed across diverse segments - from enzyme producers like Novozymes and DuPont to bio-based materials pioneers - indicating ample room for new entrants.

As process efficiencies improve and regulatory frameworks for bio-based products mature, the industry is poised to transition toward consolidation and maturation over the next decade, with large strategic partnerships and mergers likely to shape the competitive landscape.

White Biotechnology Market Key Players and Competition Synopsis

The white biotechnology market sector is characterized by a diverse competitive landscape dominated by established chemical and life-sciences firms alongside a wave of specialized biotech innovators.

Leading companies - such as Novozymes, DuPont de Nemours, BASF, Evonik Industries AG - leverage extensive R&D capabilities and global production networks to supply industrial enzymes, bio-based polymers and specialty biochemicals at scale.

At the same time, agile pure-play biotechnology companies - Amyris Inc., Genomatica Inc., Codexis Inc. and Ginkgo Bioworks - are differentiating themselves through advanced metabolic engineering, proprietary strain-development platforms and digital bioprocess optimization tools that accelerate time-to-market and reduce unit costs.

Mid-tier players including Archer Daniels Midland, Cargill Incorporated, Corbion N.V. and Lonza Group Ltd. compete on feedstock integration and circular-economy solutions, while an active M&A environment and strategic partnerships - linking chemical giants with biotech startups - continue to reshape market share, drive consolidation and foster next-generation technology transfer.

Some prominent names established in the white biotechnology market include:

  • Medtronic
  • Novozymes
  • BASF
  • DuPont
  • Cargill, Inc.
  • Royal DSM N.V.
  • Archer Daniels Midland Company
  • BioAmber Inc.
  • Lesaffre
  • Corbion N.V.
  • Evonik Industries AG
  • Genomatica, Inc
  • Ginkgo Bioworks
  • Amyris Inc.
  • TerraVia Holdings, Inc

Key Attributes:

Report Attribute Details
No. of Pages 120
Forecast Period 2025 - 2034
Estimated Market Value (USD) in 2025 $337.56 Billion
Forecasted Market Value (USD) by 2034 $672.92 Billion
Compound Annual Growth Rate 7.9%
Regions Covered GlobalĀ 

Key Topics Covered:

1. Markets: Industry Outlook

1.1 Trends: Current and Future Impact Assessment

1.2 Stakeholder Analysis

1.3 Market Dynamics Overview

1.4 Investment Landscape and R&D Trends

1.5 Future Outlook and Market Roadmap

2. White Biotechnology Market (by Application)

2.1 Application Segmentation

2.2 Application Summary

2.3 White Biotechnology Market (by Application)

2.3.1 Bioenergy

2.3.2 Food and Feed Additives

2.3.3 Pharmaceutical Ingredients

2.3.4 Personal Care and Household Products

2.3.5 Others

3. White Biotechnology Market (by Product)

3.1 Product Segmentation

3.2 Product Summary

3.3 White Biotechnology Market (by Product Type)

3.3.1 Biochemical

3.3.2 Biofuel

3.3.3 Biomaterial

3.3.4 Bioproduct

4. White Biotechnology Market (by Region)

4.1 White Biotechnology Market (by Region)

4.2 North America

4.3 Europe

4.4 Asia-Pacific

4.5 Rest-of-the-World

5. Markets - Competitive Benchmarking & Company Profiles

5.1 Next Frontiers

5.2 Geographic Assessment

5.3 Company Profiles

  • Medtronic
  • Novozymes
  • BASF SE
  • DuPont
  • Cargill, Inc.
  • Royal DSM N.V.
  • Archer Daniels Midland Company
  • BioAmber Inc.
  • Lesaffre
  • Corbion N.V.
  • Evonik Industries AG
  • Genomatica, Inc
  • Ginkgo Bioworks
  • Amyris Inc.
  • TerraVia Holdings, Inc

For more information about this report visit https://www.researchandmarkets.com/r/ula8vi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.